Healthy Skepticism Library item: 2823
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Turner J.
Weaknesses in the system of promoting and marketing drugs
Journal of Drug Issues 1974; 4:260-263
Abstract:
Although critical of several specific drug industry practices as being major contributions to the current over-medicated society controversy, Mr. Turner believes that the pharmaceutical industry can work together with consumer organizations and the public sector in resolving these issues. Of particular interest are his observations that the economic structure of current drug development and research prevents the manufacturer from assessing the impact of a drug in terms of necessary health benefits.
Keywords:
*analysis/United States/regulation of promotion/quality of prescribing/safety & risk information/sales representatives/ATTITUDES REGARDING PROMOTION: CONSUMERS/PATIENTS/INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE/PROMOTIONAL TECHNIQUES: DETAILING